First Mercantile Trust’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

First Mercantile Trust’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-938	Closed	-$59K	–	985
2020 Q1	$59K	Buy	938 +140	+18%	+$12.6K	0.01%	677
2019 Q4	$99K	Buy	798 +238	+43%	+$21.3K	0.01%	686
2019 Q3	$37K	Buy	+560	New	+$37.6K	﹤0.01%	847
2016 Q4	–	Sell	-1,027	Closed	-$169K	–	909
2016 Q3	$169K	Sell	1,027 -973	-49%	-$153K	0.02%	638
2016 Q2	$285K	Buy	2,000 +420	+27%	+$61.2K	0.04%	562
2016 Q1	$203K	Sell	1,580 -60	-4%	-$7.08K	0.02%	589
2015 Q4	$245K	Sell	1,640 -100	-6%	-$16.9K	0.03%	620
2015 Q3	$289K	Buy	1,740 +200	+13%	+$44K	0.03%	587
2015 Q2	$372K	Buy	+1,540	New	+$410K	0.03%	587
2014 Q4	–	Sell	-1,640	Closed	-$388K	–	1169
2014 Q3	$388K	Buy	+1,640	New	+$418K	0.03%	593

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

First Mercantile Trust's ICPT Position: Q2 2020 in Review

First Mercantile Trust sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2020, closing a stake of 938 shares — an estimated $59K sold.

First Mercantile Trust first reported a position in ICPT in Q3 2014 and held it in 10 quarters. The position peaked at $388K in Q3 2014. 192 funds tracked by Wall St. Rank hold ICPT as of Q2 2020.

First Mercantile Trust reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
First Mercantile Trust sold 938 Intercept Pharmaceuticals, Inc. shares in Q2 2020, an estimated $59K.
First Mercantile Trust first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 10 quarters.
First Mercantile Trust's Intercept Pharmaceuticals, Inc. position peaked at $388K in Q3 2014.
192 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2020.

Based on First Mercantile Trust's 13F filing for Q2 2020, filed 10 Aug 2020.